![Sotirios Tsimikas](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Sotirios Tsimikas
Direttore/Membro del Consiglio presso Oxitope Pharma BV
Profilo
Sotirios Tsimikas is currently working as the Director of Vascular Medicine at UC San Diego School of Medicine and as the Director at Oxitope Pharma BV.
Posizioni attive di Sotirios Tsimikas
Società | Posizione | Inizio |
---|---|---|
UC San Diego School of Medicine | Corporate Officer/Principal | - |
Oxitope Pharma BV
![]() Oxitope Pharma BV Pharmaceuticals: MajorHealth Technology Oxitope Pharma BV is a Dutch pharmaceutical start-up founded in 2020 that focuses on discovering and developing medicine for the treatment of inflammatory and cardiovascular diseases caused by oxidative stress. The company is based in Naarden, Netherlands. The Dutch company takes a different approach to the diagnosis and treatment of these diseases by preventing, halting, or reversing acute and chronic diseases driven by oxidized phospholipids. Oxitope Pharma's goal is to enable people to live long and healthy lives. The CEO is John Montana. | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Oxitope Pharma BV
![]() Oxitope Pharma BV Pharmaceuticals: MajorHealth Technology Oxitope Pharma BV is a Dutch pharmaceutical start-up founded in 2020 that focuses on discovering and developing medicine for the treatment of inflammatory and cardiovascular diseases caused by oxidative stress. The company is based in Naarden, Netherlands. The Dutch company takes a different approach to the diagnosis and treatment of these diseases by preventing, halting, or reversing acute and chronic diseases driven by oxidized phospholipids. Oxitope Pharma's goal is to enable people to live long and healthy lives. The CEO is John Montana. | Health Technology |
- Borsa valori
- Insiders
- Sotirios Tsimikas